These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 30393024

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Eslicarbazepine acetate interacts in a beneficial manner with standard and alternative analgesics to reduce trigeminal nociception.
    Pecikoza U, Tomić M, Micov A, Vuković M, Stepanović-Petrović R.
    Psychopharmacology (Berl); 2020 May; 237(5):1435-1446. PubMed ID: 32025776
    [Abstract] [Full Text] [Related]

  • 4. Vortioxetine as an analgesic in preclinical inflammatory pain models: Mechanism of action.
    Todorović M, Micov A, Nastić K, Tomić M, Pecikoza U, Vuković M, Stepanović-Petrović R.
    Fundam Clin Pharmacol; 2022 Apr; 36(2):237-249. PubMed ID: 34820899
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Possible involvement of cholinergic and opioid receptor mechanisms in fluoxetine mediated antinociception response in streptozotocin-induced diabetic mice.
    Anjaneyulu M, Chopra K.
    Eur J Pharmacol; 2006 May 24; 538(1-3):80-4. PubMed ID: 16650402
    [Abstract] [Full Text] [Related]

  • 8. Unveiling the antinociceptive mechanisms of Methyl-2-(4-chloro-phenyl)-5-benzoxazoleacetate: insights from nociceptive assays in mice.
    Jarrar Q, Ayoub R, Jarrar Y, Jaffal H, Goh KW, Ming LC, Moshawih S, Sirhan A.
    Eur Rev Med Pharmacol Sci; 2024 Mar 24; 28(5):2068-2083. PubMed ID: 38497888
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Systemic physostigmine shows antiallodynic effects in neuropathic rats.
    Pöyhiä R, Xu M, Kontinen VK, Paananen S, Kalso E.
    Anesth Analg; 1999 Aug 24; 89(2):428-33. PubMed ID: 10439760
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Role of kappa- and delta-opioid receptors in the antinociceptive effect of oxytocin in formalin-induced pain response in mice.
    Reeta Kh, Mediratta PK, Rathi N, Jain H, Chugh C, Sharma KK.
    Regul Pept; 2006 Jul 15; 135(1-2):85-90. PubMed ID: 16712978
    [Abstract] [Full Text] [Related]

  • 14. Neurotransmitter-blocking agents influence antinociceptive effects of carbamazepine, baclofen, pentazocine and morphine on bradykinin-induced trigeminal pain.
    Foong FW, Satoh M.
    Neuropharmacology; 1984 Jun 15; 23(6):633-6. PubMed ID: 6146940
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Possible involvement of supraspinal opioid and GABA receptors in CDP-choline-induced antinociception in acute pain models in rats.
    Hamurtekin E, Bagdas D, Gurun MS.
    Neurosci Lett; 2007 Jun 13; 420(2):116-21. PubMed ID: 17531379
    [Abstract] [Full Text] [Related]

  • 19. Involvement of opioid receptors in the systemic and peripheral antinociceptive actions of ellagic acid in the rat formalin test.
    Mansouri MT, Naghizadeh B, Ghorbanzadeh B.
    Pharmacol Biochem Behav; 2014 May 13; 120():43-9. PubMed ID: 24561064
    [Abstract] [Full Text] [Related]

  • 20. Antinociceptive profiles and mechanisms of orally administered coumarin in mice.
    Park SH, Sim YB, Kang YJ, Kim SS, Kim CH, Kim SJ, Lim SM, Suh HW.
    Biol Pharm Bull; 2013 May 13; 36(6):925-30. PubMed ID: 23727914
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.